Bitte benutzen Sie diese Kennung, um auf die Ressource zu verweisen:
Autoren: Barthels, Fabian
Meyr, Jessica
Hammerschmidt, Stefan J.
Marciniak, Tessa
Räder, Hans-Joachim
Ziebuhr, Wilma
Engels, Bernd
Schirmeister, Tanja
Titel: 2-sulfonylpyrimidines as privileged warheads for the development of S. aureus sortase A inhibitors
Online-Publikationsdatum: 2-Mär-2023
Erscheinungsdatum: 2021
Sprache des Dokuments: Englisch
Zusammenfassung/Abstract: Staphylococcus aureus is one of the most frequent causes of nosocomial and community-acquired infections, with emerging multiresistant isolates causing a significant burden to public health systems. We identified 2-sulfonylpyrimidines as a new class of potent inhibitors against S. aureus sortase A acting by covalent modification of the active site cysteine 184. Series of derivatives were synthesized to derive structure-activity relationship (SAR) with the most potent compounds displaying low micromolar KI values. Studies on the inhibition selectivity of homologous cysteine proteases showed that 2-sulfonylpyrimidines reacted efficiently with protonated cysteine residues as found in sortase A, though surprisingly, no reaction occurred with the more nucleophilic cysteine residue from imidazolinium-thiolate dyads of cathepsin-like proteases. By means of enzymatic and chemical kinetics as well as quantum chemical calculations, it could be rationalized that the SNAr reaction between protonated cysteine residues and 2-sulfonylpyrimidines proceeds in a concerted fashion, and the mechanism involves a ternary transition state with a conjugated base. Molecular docking and enzyme inhibition at variable pH values allowed us to hypothesize that in sortase A this base is represented by the catalytic histidine 120, which could be substantiated by QM model calculation with 4-methylimidazole as histidine analog.
DDC-Sachgruppe: 570 Biowissenschaften
570 Life sciences
610 Medizin
610 Medical sciences
Veröffentlichende Institution: Johannes Gutenberg-Universität Mainz
Organisationseinheit: FB 09 Chemie, Pharmazie u. Geowissensch.
Veröffentlichungsort: Mainz
Version: Published version
Publikationstyp: Zeitschriftenaufsatz
Nutzungsrechte: CC BY
Informationen zu den Nutzungsrechten:
Zeitschrift: Frontiers in molecular biosciences
Seitenzahl oder Artikelnummer: 804970
Verlag: Frontiers
Verlagsort: Lausanne
Erscheinungsdatum: 2021
ISSN: 2296-889X
DOI der Originalveröffentlichung: 10.3389/fmolb.2021.804970
Enthalten in den Sammlungen:JGU-Publikationen

Dateien zu dieser Ressource:
  Datei Beschreibung GrößeFormat
2sulfonylpyrimidines_as_privi-20230302115838017.pdf2.52 MBAdobe PDFÖffnen/Anzeigen